HPS Pharmacies wish to advise that multiple suppliers are experiencing a supply interruption for amoxicillin 250mg/5mL suspension, as follows:
|Product||ARTG||Expected return date|
|APO-Amoxycillin Suspension||137883||Late January 2023|
|Amoxycillin Sandoz Suspension||93720||Mid-October 2022|
|Amoxil® Forte Sugar-Free Syrup||11134||Mid-November 2022|
This supply interruption is due to an unexpected increase in demand.
An internationally registered brand of amoxicillin 250mg/5mL suspension has been approved for supply under Section 19A of the Therapeutic Goods Act 1989.
Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact your pharmacist at HPS Pharmacies.
Subscribe Knowledge Centre Updates
Enter your details to receive Knowledge Centre updates